Related Experiment Videos

Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors

Lars Tatenhorst1, Eric Hahnen, Michael T Heneka

  • 1Department of Neurology, University of Bonn, Sigmund-Freud-Street 25, 53105 Bonn, Germany.

PPAR Research
|August 30, 2008
PubMed

Insights

Peroxisome proliferator-activated receptors (PPARs) show promise in treating central nervous system (CNS) tumors. PPAR agonists, especially thiazolidinediones, demonstrate anti-cancer and redifferentiation effects, suggesting new therapeutic avenues.

Area of Science:

  • Molecular biology
  • Oncology
  • Neuroscience

Background:

  • Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors.
  • PPAR agonists show anti-cancer and redifferentiation effects in central nervous system (CNS) tumors.
  • Mechanisms of PPAR action in CNS tumors are still under investigation, with some conflicting in vitro data.

Purpose of the Study:

  • To explore the potential of PPAR agonists in CNS tumor therapy.
  • To summarize emerging findings on PPARs in CNS tumor treatment.
  • To highlight thiazolidinediones as promising therapeutic candidates.

Main Methods:

  • Review of existing literature on PPARs and CNS tumors.
  • Analysis of in vitro studies on tumor cell treatment.
  • Examination of emerging in vivo studies.

Main Results:

  • PPAR agonists exhibit significant antineoplastic and redifferentiation effects.
  • In vitro studies show partially controversial findings regarding PPAR influence.
  • In vivo studies are beginning to emerge, indicating therapeutic potential.

Conclusions:

  • PPAR agonists, particularly thiazolidinediones, represent promising candidates for novel human CNS tumor therapies.
  • Further in vivo research is crucial to fully elucidate the therapeutic efficacy of PPARs in CNS oncology.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...